What is Doximity's R&D?

Doximity (DOCS) reported R&D of $39.11M in Q1 2026.

How has Doximity's R&D changed year-over-year?

Doximity's R&D increased by 57.7% year-over-year, from $24.8M to $39.11M.

What is the long-term trend for Doximity's R&D?

Over 4 years (2022 to 2026), Doximity's R&D has grown at a 20.3% compound annual growth rate (CAGR), from $62.35M to $130.7M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

Doximity DOCS R&D

R&D at other companies

MicrosoftMSFT

$8.92B+8.7%

Veeva SystemsVEEV

$208.32M+13.2%

SolventumSOLV

$189M-2.1%

Amneal Pharmaceuticals, Inc.AMRX

$38.38M-4.1%

Mirum Pharmaceuticals, Inc.MIRM

$97.91M+139%

Becton, Dickinson and CompanyBDX

$249M+7.3%

Other financials

Income statement

See full

Revenue$145.4M+5.1%

Gross profit$126.0M+1.7%

Operating income$24.8M-49.0%

Net income$19.1M-69.4%

EPS (diluted)$0.10-67.7%

Balance sheet

See full

Cash & equivalents$219.2M+4.6%

Total debt$10.2M-17.8%

Total equity$950.8M-12.2%

Total assets$1.1B-11.1%

Cash flow

See full

Operating cash flow$109.5M+11.2%

CapEx-—

Free cash flow$81.6M-17.1%

Valuation

See full

Market cap$3.74B-60.5%

Enterprise value$3.53B-61.7%

P/E19.1×-23.3×

P/S5.8×-10.8×

Profitability

See full

Gross margin89.1%-1.1pp

Operating margin33.3%-6.6pp

Net margin30.4%-8.7pp

FCF margin50.6%+2.7pp

Returns & leverage

See full

Return on equity19.3%-3.2pp

Debt / equity0×0.0×

Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Doximity's R&D?: Doximity (DOCS) reported R&D of $39.11M in Q1 2026.
How has Doximity's R&D changed year-over-year?: Doximity's R&D increased by 57.7% year-over-year, from $24.8M to $39.11M.
What is the long-term trend for Doximity's R&D?: Over 4 years (2022 to 2026), Doximity's R&D has grown at a 20.3% compound annual growth rate (CAGR), from $62.35M to $130.7M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.